Abbonarsi

Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy - 23/09/21

Doi : 10.1016/j.diii.2021.05.007 
Amandine Crombé a, b, c, , Lisa Gauquelin d, Stéphanie Nougaret e, Marine Chicart f, Marina Pulido d, Anne Floquet g, Frédéric Guyon h, Sabrina Croce i, Michèle Kind a, Anne-Laure Cazeau f
a Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
b Bordeaux University, 33000 Bordeaux, France 
c Modelisation in Oncology (MOnc) Team, INRIA Bordeaux-Sud-Ouest, CNRS UMR 5251, 33405, Talence, France 
d Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
e Department of Radiology, Montpellier Cancer Institute, University of Montpellier, 34090 Montpellier, France 
f Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
g Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
h Department of Oncological Surgery, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
i Department of Pathology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 

Corresponding author at: Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, Bordeaux 33000, France.Institut Bergonié, Comprehensive Cancer Center of Nouvelle-AquitaineBordeaux33000France

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

Visual assessment of MRI and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography shows high inter- and intra-observer agreements on baseline examinations.
SUV-max, SUL-peak, SUV-mean at baseline and their changes show at least good reproducibility.
The measurement used and the evaluation time significantly influence the reproducibility.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Purpose

To investigate the reproducibility of diffusion-weighted (DW) MRI and 18F-Fluorodeoxyglucose (18F-FDG)-Positron emission tomography/CT (PET/CT) in monitoring response to neoadjuvant chemotherapy in epithelial ovarian cancer.

Materials and methods

Ten women (median age, 67 years; range: 41.8–77.3 years) with stage IIIC-IV epithelial ovarian cancers were included in this prospective trial (NCT02792959) between 2014 and 2016. All underwent initial laparoscopic staging, four cycles of carboplatine-paclitaxel-based chemotherapy and interval debulking surgery. PET/CT and DW-MRI were performed at baseline (C0), after one cycle (C1) and before surgery (C4). Two nuclear physicians and two radiologists assessed five anatomic sites for the presence of ≥1 lesion. Target lesions in each site were defined and their apparent diffusion coefficient (ADC), maximal standardized uptake value (SUV-max), SUV-mean, SUL-peak, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were monitored (i.e., 10 patients ×5 sites ×3 time-points). Their relative early and late changes were calculated. Intra/inter-observer reproducibilities of qualitative and quantitative analysis were estimated with Kappa and intra-class correlation coefficients (ICCs).

Results

For both modalities, inter- and intra-observer agreement percentages were excellent for initial staging but declined later for DW-MRI, leading to lower Kappa values for inter- and intra-observer variability (0.949 and 1 at C0, vs. 0.633 and 0.643 at C4, respectively) while Kappa values remained>0.8 for PET/CT. Inter- and intra-observer ICCs were>0.75 for SUV-max, SUL-peak, SUV-mean and their change regardless the time-point. ADC showed lower ICCs (range: 0.013–0.811). ANOVA found significant influences of the evaluation time, the measurement used (ADC, SUV-max, SUV-mean, SUV-max, SUL-peak, MTV or TLG) and their interaction on ICC values (P=0.0023, P<0.0001 and P =0.0028, respectively).

Conclusion

While both modalities demonstrated high reproducibility at baseline, only SUV-max, SUL-peak, SUV-mean and their changes maintained high reproducibility during chemotherapy.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Carcinoma, Ovarian epithelial, Diffusion-weighted magnetic resonance imaging, Positron-emission tomography/Computed tomography, Reproducibility of results, Biomarkers, Tumors

Abbreviations : 18F-FDG, ADC, ANOVA, C0, C1, C4, CE, CI, dC0C1, dC0C4, DWI, ICC, LOA, MTV, PCI, PET/CT, ROI, SD, SUL-peak, SUV-max, SUV-mean, TLG


Mappa


© 2021  Société française de radiologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 102 - N° 10

P. 629-639 - ottobre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Intracranial venous sinus stenting for the treatment of lateral sinus stenoses: An analysis of 200 patients
  • Marc-Antoine Labeyrie, Matteo Fantoni, Ursula Vever, Alexis Guedon, Sophie Bonnin, Anne-Laure Bernat, Benjamin Verillaud, Emmanuel Houdart
| Articolo seguente Articolo seguente
  • Reduced nontarget embolization and increased targeted delivery with a reflux-control microcatheter in a swine model
  • Silvia Rizzitelli, Nir Holtzman, Geert Maleux, Thierry De Baere, Fei Sun, Pierre-Olivier Comby, Michael Tal, Gwenaelle Bazin, Francois Montestruc, Thomas Viel, Philippe Robert, Osnat Harbater, Eran Miller, Claire Corot

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.